New York 2025 Session Status: Introduced

A1647 — Relates to decriminalizing the possession of buprenorphine

Last action — In Assembly Committee

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Assembly
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Assembly. Introduced January 10, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

The bill decriminalizes the possession of buprenorphine.

This legislation aims to remove legal penalties for possessing buprenorphine. However, the specific details of the bill's provisions are not available.

Summary

Decriminalizes the possession of buprenorphine from certain crimes.

Bill Text

How this bill changes current law

1 change Share ↗

Compared against the New York Consolidated Laws as published AI-generated reading aid — verify against the official bill.

This bill amends 1 section(s) of the New York Consolidated Laws: Section 220.00 of the penal law.

  • Section 220.00 of the penal law

    other than buprenorphine , other than buprenorphine italics

    amended

Action History

  1. AMEND BY RESTORING TO ORIGINAL PRINT 1647

  2. REFERRED TO CODES

  3. PRINT NUMBER 1647A

  4. AMEND AND RECOMMIT TO CODES

  5. REFERRED TO CODES

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 218 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (218)

218 members have not signed on to this bill.

Show all 218 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does A1647 do?
Decriminalizes the possession of buprenorphine from certain crimes.
Who sponsors A1647?
A1647 is sponsored by Linda Rosenthal.
What is the current status of A1647?
This bill has been introduced in the Assembly. Introduced January 10, 2025. It must pass committee before a floor vote.
Where can I track A1647?
Track A1647 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on A1647

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of A1647

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →